HRTX
Price
$2.14
Change
-$0.02 (-0.93%)
Updated
Jun 27 closing price
Capitalization
326.49M
45 days until earnings call
VXRT
Price
$0.49
Change
-$0.04 (-7.55%)
Updated
Jun 27 closing price
Capitalization
112.86M
40 days until earnings call
Interact to see
Advertisement

HRTX vs VXRT

Header iconHRTX vs VXRT Comparison
Open Charts HRTX vs VXRTBanner chart's image
Heron Therapeutics
Price$2.14
Change-$0.02 (-0.93%)
Volume$5.48M
Capitalization326.49M
Vaxart
Price$0.49
Change-$0.04 (-7.55%)
Volume$2.87M
Capitalization112.86M
HRTX vs VXRT Comparison Chart in %
Loading...
HRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VXRT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HRTX vs. VXRT commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HRTX is a StrongBuy and VXRT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (HRTX: $2.14 vs. VXRT: $0.49)
Brand notoriety: HRTX and VXRT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HRTX: 326% vs. VXRT: 57%
Market capitalization -- HRTX: $326.49M vs. VXRT: $112.86M
HRTX [@Biotechnology] is valued at $326.49M. VXRT’s [@Biotechnology] market capitalization is $112.86M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HRTX’s FA Score shows that 0 FA rating(s) are green whileVXRT’s FA Score has 0 green FA rating(s).

  • HRTX’s FA Score: 0 green, 5 red.
  • VXRT’s FA Score: 0 green, 5 red.
According to our system of comparison, VXRT is a better buy in the long-term than HRTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HRTX’s TA Score shows that 6 TA indicator(s) are bullish while VXRT’s TA Score has 4 bullish TA indicator(s).

  • HRTX’s TA Score: 6 bullish, 3 bearish.
  • VXRT’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, HRTX is a better buy in the short-term than VXRT.

Price Growth

HRTX (@Biotechnology) experienced а +7.00% price change this week, while VXRT (@Biotechnology) price change was -14.74% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.22%. For the same industry, the average monthly price growth was +31.37%, and the average quarterly price growth was +12.88%.

Reported Earning Dates

HRTX is expected to report earnings on Aug 12, 2025.

VXRT is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HRTX($326M) has a higher market cap than VXRT($113M). HRTX YTD gains are higher at: 39.869 vs. VXRT (-25.313). HRTX has higher annual earnings (EBITDA): 2.76M vs. VXRT (-45.73M). HRTX has more cash in the bank: 50.7M vs. VXRT (41.9M). VXRT has less debt than HRTX: VXRT (16.8M) vs HRTX (177M). HRTX has higher revenues than VXRT: HRTX (149M) vs VXRT (47.4M).
HRTXVXRTHRTX / VXRT
Capitalization326M113M288%
EBITDA2.76M-45.73M-6%
Gain YTD39.869-25.313-158%
P/E RatioN/AN/A-
Revenue149M47.4M314%
Total Cash50.7M41.9M121%
Total Debt177M16.8M1,054%
FUNDAMENTALS RATINGS
HRTX vs VXRT: Fundamental Ratings
HRTX
VXRT
OUTLOOK RATING
1..100
1283
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
34
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
4850
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VXRT's Valuation (34) in the Biotechnology industry is somewhat better than the same rating for HRTX (67). This means that VXRT’s stock grew somewhat faster than HRTX’s over the last 12 months.

VXRT's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as HRTX (100). This means that VXRT’s stock grew similarly to HRTX’s over the last 12 months.

VXRT's SMR Rating (98) in the Biotechnology industry is in the same range as HRTX (100). This means that VXRT’s stock grew similarly to HRTX’s over the last 12 months.

HRTX's Price Growth Rating (48) in the Biotechnology industry is in the same range as VXRT (50). This means that HRTX’s stock grew similarly to VXRT’s over the last 12 months.

HRTX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as VXRT (100). This means that HRTX’s stock grew similarly to VXRT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HRTXVXRT
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 5 days ago
83%
Bullish Trend 16 days ago
74%
Declines
ODDS (%)
Bearish Trend 16 days ago
86%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
HRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VXRT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CRMAX9.990.05
+0.50%
CRM Small/Mid Cap Value Inv
CMCRX42.490.14
+0.33%
Calvert US Mid Cap Core Rspnb Idx R6
IAFEX13.79N/A
N/A
FI Instl Grp All Frgn Eq Env & Scl Val
JACFX19.28-0.01
-0.05%
JHancock Mid Cap Growth NAV
MSGUX49.07-0.15
-0.30%
Morgan Stanley Inst Growth C

HRTX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, HRTX has been loosely correlated with GSGTF. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if HRTX jumps, then GSGTF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HRTX
1D Price
Change %
HRTX100%
-0.93%
GSGTF - HRTX
45%
Loosely correlated
N/A
AMRN - HRTX
44%
Loosely correlated
-1.19%
ABOS - HRTX
39%
Loosely correlated
-7.44%
ACAD - HRTX
38%
Loosely correlated
-0.41%
ARDX - HRTX
38%
Loosely correlated
+0.14%
More

VXRT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VXRT has been loosely correlated with AXON. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if VXRT jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VXRT
1D Price
Change %
VXRT100%
-8.09%
AXON - VXRT
50%
Loosely correlated
+1.82%
ARRY - VXRT
48%
Loosely correlated
-0.92%
AMRN - VXRT
42%
Loosely correlated
-1.19%
ALNY - VXRT
39%
Loosely correlated
+1.44%
ARCT - VXRT
37%
Loosely correlated
-7.49%
More